FDA clears wireless cardiac monitor
IntriCon has received FDA 510(k) clearance for the first-generation wireless cardiac diagnostic monitoring device, which offers wireless transmission of patient data so physicians can continuously monitor cardiac events remotely.

The Centauri Ambulatory Patient ECG provides diagnostic evaluation of patients who experience transient symptoms that may suggest cardiac arrhythmia, according to a company release. The device offers continuous monitoring, arrhythmia detection and wireless transmission of recorded cardiac activity.

The Arden Hill, Minn.-based device developer expects to release the product in the third quarter.

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup